Here you will find our latest press release.
For publications, please name the copyright as indicated in the pictures.
Testbiotech: The publicly funded research institution should take on a role model function
Testbiotech has filed an opposition against Patent EP2328918 issued to the Max Planck Society, based in Munich. This patent claims genetically engineered animals, even including primates as “inventions”. Testbiotech believes the patent constitutes an unacceptable violation of ethical boundaries. In a letter to the president of the Max Planck Society, Testbiotech is now arguing that the publicly funded German research institution should take a leading role in protecting the interests of civil society, and initiate changes to the patent of its own accord.
For inquiries or interviews, please contact Christoph Then.
Would you like to be included in our press mailing list?
Please send us an e-mail with subject "Press mailing" to the e-mail address above.
EFSA and Monsanto are ignoring risks for farmers and the environment
Concerns about health risks due to residues from spraying glyphosate in combination with other herbicides
Controversy about the health risks of genetically engineered soybeans
“Revolving doors with industry are fast becoming EFSA´s main entrance”
Soaring number of patent applications including those on farm animals